💊 Think Clinical Judgment Is Enough for Drug Delivery Decisions? Think Again.

In oncology, selecting the right therapy is only half the battle. The other half? Navigating complex drug policies that dictate how and if you’ll get reimbursed.

📉 Even FDA-approved treatments can be denied if they fall outside Medicare’s Local or National Coverage Determinations (LCDs/NCDs).
⚠️ Medicaid policies vary drastically by state — one wrong step can lead to claim denials and compliance risks.
🚫 And don’t forget commercial payers with strict carve-out rules that can block buy-and-bill entirely.

If your practice isn’t aligned with these policies, you're not just risking revenue—you’re risking delays in patient care.

🧠 In our latest blog, we break down:

• Why LCD/NCD awareness must be part of your workflow

• How state Medicaid rules can impact infused drug billing

• What commercial pharmacy mandates mean for your procurement model

• And how policy non-compliance could trigger audits or non-payment

✅ Learn how top-performing oncology practices use policy awareness as a strategic advantage — and how Confair can help you do the same.

👉 [Read the full blog here] – Stay compliant, stay profitable, and focus on delivering care.